These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3595812)

  • 1. Familial malignant blood disease in the country of Jämtland, Sweden.
    Eriksson M; Bergström I
    Eur J Haematol; 1987 Mar; 38(3):241-5. PubMed ID: 3595812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial occurrence of chronic lymphocytic leukaemia in Norway.
    Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
    Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.
    Eriksson M; Hållberg B
    Cancer Causes Control; 1992 Jan; 3(1):63-7. PubMed ID: 1536915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of hematopoietic malignancies in a well-defined population in France.
    Carli PM; Milan C; Lorenzini JL; Guy H; Michiels R
    Oncology; 1986; 43(6):354-7. PubMed ID: 3808567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative and myeloproliferative disease in Tasmania.
    Lickiss JN; Baikie AG; Panton J
    Natl Cancer Inst Monogr; 1977 Dec; 47():37-9. PubMed ID: 613244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S; Brière J; Bernard J
    Nouv Rev Fr Hematol (1978); 1978 Apr; 20(1):1-15. PubMed ID: 353725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiologic features of Philadelphia-negative chronic myeloproliferative disorders in Szabolcs-Szatmár-Bereg county, Hungary. Analysis of data of a 33-year period].
    Jakó J; Szerafin L
    Orv Hetil; 2017 Apr; 158(15):572-578. PubMed ID: 28393599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective epidemiological study of hemopoietic system neoplasms in Argentina.
    Quiroga Micheo E; Calcagno EJ; Calabria SI; Besuschio SC; Magnasco JH; Sackmann Muriel F; Maccione E; Barros C; Santoro A; de Soto ZC
    Medicina (B Aires); 1981; 41(2):187-200. PubMed ID: 7278616
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concurrent lymphoproliferative and myeloproliferative disorders in three patients].
    Hernández Sánchez MC; García Quiroga H; Ulibarrena Redondo C; Méndez Sánchez JA
    An Med Interna; 2008 Feb; 25(2):78-80. PubMed ID: 18432364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of hemoblastosis].
    Gus'kova AK
    Probl Gematol Pereliv Krovi; 1979 Feb; 24(2):58-9. PubMed ID: 424405
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: occupational and familial aspects.
    Giles GG; Lickiss JN; Baikie MJ; Lowenthal RM; Panton J
    J Natl Cancer Inst; 1984 Jun; 72(6):1233-40. PubMed ID: 6587145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytogenetic study of exudates secondary to hematologic processes].
    Bello MJ; Rey JA; Moreno S; Martínez Castro P; Benítez J
    Sangre (Barc); 1988 Jun; 33(3):165-70. PubMed ID: 3175812
    [No Abstract]   [Full Text] [Related]  

  • 13. Marker chromosome 14q + in human cancer and leukemia.
    Mitelman F
    Adv Cancer Res; 1981; 34():141-70. PubMed ID: 7025591
    [No Abstract]   [Full Text] [Related]  

  • 14. Myeloproliferative and lymphoproliferative disorders in Tasmania, 1972-80: patterns in space and time.
    Lickiss JN; Giles GG; Baikie MJ; Lowenthal RM; Challis D; Panton J
    J Natl Cancer Inst; 1984 Jun; 72(6):1223-31. PubMed ID: 6587144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles and results of 5 years' work on a register of hemoblastoses].
    Lapin BA; Lebedeva IuL; Lebedev VN; Iakovleva LA; Finchenko GA
    Vopr Onkol; 1980; 26(1):18-23. PubMed ID: 6444476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome abnormalities in malignant hematologic disorders.
    Dewald GW; Noel P; Dahl RJ; Spurbeck JL
    Mayo Clin Proc; 1985 Oct; 60(10):675-89. PubMed ID: 3897733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders.
    Jønsson V; Awan H; Jones ND; Johannesen TB; Thøgersen K; Steig BÁ; Andorsdottir G; Tjønnfjord GE
    Sci Rep; 2022 Apr; 12(1):6138. PubMed ID: 35413962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
    Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
    Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.